Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (327) 327
Book Review (39) 39
Publication (13) 13
Book Chapter (9) 9
Conference Proceeding (8) 8
Book / eBook (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (162) 162
index medicus (161) 161
male (154) 154
urology & nephrology (123) 123
prostate cancer (122) 122
aged (77) 77
urology (76) 76
prostatic neoplasms - pathology (75) 75
middle aged (74) 74
cancer (71) 71
magnetic resonance imaging (60) 60
biopsy (54) 54
diagnosis (49) 49
prostatic neoplasms - diagnosis (41) 41
prostate (40) 40
prostate - pathology (39) 39
oncology (37) 37
prostatic neoplasms - surgery (36) 36
radical prostatectomy (36) 36
neoplasm staging (31) 31
prostate-specific antigen - blood (31) 31
female (30) 30
adult (29) 29
men (29) 29
abridged index medicus (28) 28
mortality (28) 28
prostatectomy (28) 28
prognosis (26) 26
analysis (24) 24
mri (24) 24
prostatic neoplasms (23) 23
risk factors (23) 23
surgery (23) 23
survival (22) 22
tumors (21) 21
care and treatment (20) 20
aged, 80 and over (19) 19
focal therapy (19) 19
health aspects (19) 19
prostatic neoplasms - blood (19) 19
prostatic neoplasms - therapy (19) 19
research (19) 19
urology and nephrology (19) 19
prostate-specific antigen (18) 18
retrospective studies (18) 18
treatment outcome (18) 18
active surveillance (17) 17
magnetic resonance imaging - methods (17) 17
medicine & public health (17) 17
pathology (17) 17
prostatectomy - methods (17) 17
prostatic neoplasms - diagnostic imaging (17) 17
risk (17) 17
screening (17) 17
adenocarcinoma (16) 16
kidney neoplasms - pathology (16) 16
neoplasm grading (16) 16
prostatic neoplasms - epidemiology (16) 16
antigen (15) 15
carcinoma (15) 15
oncology, experimental (15) 15
prostate neoplasms (15) 15
therapy (15) 15
life sciences (14) 14
kidney neoplasms - surgery (13) 13
neoplasm invasiveness (13) 13
nephrectomy (13) 13
risk assessment (13) 13
usage (13) 13
volume (13) 13
antigens (12) 12
article (12) 12
multiparametric mri (12) 12
nephrology (12) 12
outcomes (12) 12
predictive value of tests (12) 12
urologi och njurmedicin (12) 12
adenocarcinoma - pathology (11) 11
carcinoma, renal cell (11) 11
carcinoma, renal cell - pathology (11) 11
carcinoma, renal cell - surgery (11) 11
contrast-enhanced mri (11) 11
disease progression (11) 11
europe (11) 11
follow-up (11) 11
mass screening (11) 11
metastasis (11) 11
prospective studies (11) 11
prostatic neoplasms - mortality (11) 11
ultrasonography (11) 11
ultrasound (11) 11
ablation (10) 10
digital rectal examination (10) 10
early detection of cancer (10) 10
experience (10) 10
follow-up studies (10) 10
france (10) 10
prostate - diagnostic imaging (10) 10
quality of life (10) 10
epidemiology (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Editorial Comment
by Villers, Arnauld
Journal of Urology, ISSN 0022-5347, 10/2016, Volume 196, Issue 4, pp. 1266 - 1267
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Editorial Comment
by Villers, Arnauld
The Journal of Urology, ISSN 0022-5347, 10/2016, Volume 196, Issue 4, pp. 1266 - 1267
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Editorial Comment
by Villers, Arnauld
Journal of Urology, ISSN 0022-5347, 10/2016, Volume 196, Issue 4, pp. 1266 - 1267
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Editorial Comment
by Villers, Arnauld
Journal of Urology, The, ISSN 0022-5347, 2016
Urology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Editorial Comment
by Villers, Arnauld and Puech, Philippe
Journal of Urology, ISSN 0022-5347, 11/2018, Volume 200, Issue 5, p. 1121
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Editorial Comment
by Villers, Arnauld and Puech, Philippe
Journal of Urology, ISSN 0022-5347, 11/2018, Volume 200, Issue 5, pp. 1121 - 1121
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
by Schröder, Fritz H, Prof and Hugosson, Jonas, Prof and Roobol, Monique J, PhD and Tammela, Teuvo L J, Prof and Zappa, Marco, MD and Nelen, Vera, MD and Kwiatkowski, Maciej, MD and Lujan, Marcos, MD and Määttänen, Liisa, PhD and Lilja, Hans, Prof and Denis, Louis J, Prof and Recker, Franz, Prof and Paez, Alvaro, MD and Bangma, Chris H, Prof and Carlsson, Sigrid, MD and Puliti, Donella, MSc and Villers, Arnauld, MD and Rebillard, Xavier, MD and Hakama, Matti, Prof and Stenman, Ulf-Hakan, Prof and Kujala, Paula, MD and Taari, Kimmo, MD and Aus, Gunnar, MD and Huber, Andreas, Prof and van der Kwast, Theo H, Prof and van Schaik, Ron H N, Prof and de Koning, Harry J, Prof and Moss, Sue M, Prof and Auvinen, Anssi, Prof and ERSPC Investigators and Sahlgrenska akademin and Göteborgs universitet and Gothenburg University and Institute of Clinical Sciences, Section for Oncology, Radiation Physics, Radiology and Urology, Department of Urology and Institutionen för kliniska vetenskaper, sektionen för onkologi, radiofysik, radiologi och urologi, Avdelningen för urologi and Sahlgrenska Academy
The Lancet, ISSN 0140-6736, 2014, Volume 384, Issue 9959, pp. 2027 - 2035
Summary Background The European Randomised study of Screening for Prostate Cancer (ERSPC) has shown significant reductions in prostate cancer mortality after 9... 
Internal Medicine | TRIAL | MEDICINE, GENERAL & INTERNAL | RISK | DEATH | BIOPSY | ANTIGEN | Follow-Up Studies | Europe | Humans | Middle Aged | Male | Aged | Prostatic Neoplasms - diagnosis | Prostate-Specific Antigen - analysis | Prostatic Neoplasms - mortality | Medical screening | Prostate cancer | Mortality | Age | Men | Index Medicus | Abridged Index Medicus | Urologi och njurmedicin | Cancer and Oncology | Urology and Nephrology | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Risk of biochemical recurrence based on extent and location of positive surgical margins after robot-assisted laparoscopic radical prostatectomy
by Gautier, Marcq and Gautier, Marcq and Aude, Michelet and Aude, Michelet and Gerjon, Hannink and Gerjon, Hannink and Jerome, Rizk and Jerome, Rizk and Jean, Sauvain and Jean, Sauvain and Arnauld, Villers and Arnauld, Villers and Mo, Saffarini and Mo, Saffarini and Charles, H Rochat and Charles, H. Rochat
BMC cancer, ISSN 1471-2407, 12/2018, Volume 18, Issue 1, pp. 1291 - 1291
BackgroundThere are no published studies on the simultaneous effect of extent and location of positive surgical margins (PSMs) on biochemical recurrence (BCR)... 
Prostatectomy | Laparoscopy | Positive surgical margins | Biochemical recurrence | Prostate cancer | Robot-assisted | EVENTS | LENGTH | CANCER | PREDICTION | RATES | IMPACT | ONCOLOGY | OUTCOMES | Risk Assessment - methods | Prostatectomy - methods | Follow-Up Studies | Humans | Middle Aged | Male | Prostate - surgery | Incidence | Neoplasm Recurrence, Local - pathology | Prostate - pathology | Laparoscopy - methods | Neoplasm Grading | Prostatic Neoplasms - blood | Kallikreins - blood | Retrospective Studies | Neoplasm Recurrence, Local - blood | Robotic Surgical Procedures - methods | Prostatic Neoplasms - pathology | Prostatic Neoplasms - surgery | Margins of Excision | Prostate-Specific Antigen - blood | Prostatic Neoplasms - epidemiology | Disease-Free Survival | Biopsy | Survival Analysis | Aged | Neoplasm Recurrence, Local - epidemiology | Neoplasm Staging | Usage | Relapse | Care and treatment | Analysis | Health risk assessment | Risk factors | Diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study
by Shore, Neal D, Dr and Chowdhury, Simon, MD and Villers, Arnauld, Prof and Klotz, Laurence, MD and Siemens, D Robert, Prof and Phung, De, BSc and van Os, Steve, MD and Hasabou, Nahla, MD and Wang, Fong, MD and Bhattacharya, Suman, PhD and Heidenreich, Axel, Prof
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 153 - 163
Summary Background Enzalutamide is an oral androgen-receptor inhibitor that has been shown to improve survival in two placebo-controlled phase 3 trials, and is... 
Hematology, Oncology and Palliative Medicine | TRIAL | THERAPY | ONCOLOGY | GUIDELINES | MEN | ANTIANDROGEN WITHDRAWAL SYNDROME | CRPC | CHEMOTHERAPY | Back Pain - chemically induced | Phenylthiohydantoin - adverse effects | Dyspnea - chemically induced | Myocardial Infarction - chemically induced | Anilides - therapeutic use | Nausea - chemically induced | Phenylthiohydantoin - therapeutic use | Anilides - adverse effects | Humans | Middle Aged | Male | Fatigue - chemically induced | Patient Dropouts | Arthralgia - chemically induced | Fractures, Spontaneous - chemically induced | Hypertension - chemically induced | Aged, 80 and over | Hydronephrosis - chemically induced | Double-Blind Method | Anemia - chemically induced | Prostatic Neoplasms, Castration-Resistant - drug therapy | Disease Progression | Phenylthiohydantoin - analogs & derivatives | Constipation - chemically induced | Disease-Free Survival | Tosyl Compounds - adverse effects | Tosyl Compounds - therapeutic use | Aged | Nitriles - adverse effects | Heart Failure - chemically induced | Hot Flashes - chemically induced | Nitriles - therapeutic use | Care and treatment | Cancer patients | Oncology, Experimental | Clinical trials | Metastasis | Research | Prostate cancer | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Re: Improving Detection of Clinically Significant Prostate Cancer: MRI/TRUS Fusion-guided Prostate Biopsy
by Villers, Arnauld
European Urology, ISSN 0302-2838, 2014, Volume 65, Issue 6, pp. 1218 - 1219
Urology | UROLOGY & NEPHROLOGY | Magnetic resonance imaging | Prostate cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Editorial Comment
by Villers, Arnauld
The Journal of urology, 10/2016, Volume 196, Issue 4, p. 1266
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Re: Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy
by Villers, Arnauld and Rubin, Mark A
European Urology, ISSN 0302-2838, 2016, Volume 71, Issue 2, pp. 301 - 301
Urology | Prostate-Specific Antigen | Neoplasm Grading | Prognosis | Prostatic Neoplasms - surgery | Humans | Male | Prostatectomy | Prostate cancer | Surgery | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection
by Haffner, Jérémie and Lemaitre, Laurent and Puech, Philippe and Haber, Georges‐Pascal and Leroy, Xavier and Jones, J. Stephen and Villers, Arnauld
BJU International, ISSN 1464-4096, 10/2011, Volume 108, Issue 8b, pp. E171 - E178
OBJECTIVE To compare magnetic resonance imaging (MRI)-targeted biopsies with extended systematic biopsies for the detection of significant prostate cancer.... 
biopsy | diagnosis | magnetic resonance imaging | prostate neoplasms | prognosis | CONTRAST-ENHANCED MRI | ZONE | VOLUME | TIME | THERAPY | GUIDED BIOPSY | UROLOGY & NEPHROLOGY | ANTIGEN | Magnetic Resonance Imaging | Prostatic Neoplasms - pathology | Humans | Middle Aged | Aged, 80 and over | Male | Aged | Prostatic Neoplasms - diagnosis | Biopsy, Needle - methods | Antigens | Magnetic resonance imaging | Oncology, Experimental | Research | Diagnosis | Comparative analysis | Prostate cancer | Tumors | Cancer | Biopsy | Nuclear magnetic resonance--NMR | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
by Kasivisvanathan, Veeru and Rannikko, Antti S and Borghi, Marcelo and Panebianco, Valeria and Mynderse, Lance A and Vaarala, Markku H and Briganti, Alberto and Budäus, Lars and Hellawell, Giles and Hindley, Richard G and Roobol, Monique J and Eggener, Scott and Ghei, Maneesh and Villers, Arnauld and Bladou, Franck and Villeirs, Geert M and Virdi, Jaspal and Boxler, Silvan and Robert, Grégoire and Singh, Paras B and Venderink, Wulphert and Hadaschik, Boris A and Ruffion, Alain and Hu, Jim C and Margolis, Daniel and Crouzet, Sébastien and Klotz, Laurence and Taneja, Samir S and Pinto, Peter and Gill, Inderbir and Allen, Clare and Giganti, Francesco and Freeman, Alex and Morris, Stephen and Punwani, Shonit and Williams, Norman R and Brew-Graves, Chris and Deeks, Jonathan and Takwoingi, Yemisi and Emberton, Mark and Moore, Caroline M and PRECISION Study Grp Collaborators and PRECISION Study Group Collaborators
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 19, pp. 1767 - 1777
Prostate-cancer biopsy directed at areas of MRI abnormality was compared with standard transrectal ultrasonographic biopsy for diagnostic specificity and... 
MEDICINE, GENERAL & INTERNAL | COST-EFFECTIVENESS | FUSION | ACTIVE SURVEILLANCE | MEN | MAGNETIC-RESONANCE | OUTCOMES | ULTRASOUND-GUIDED BIOPSY | Biopsy - methods | Prostatic Neoplasms - pathology | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Ultrasonography, Interventional | Male | Biopsy - adverse effects | Magnetic Resonance Imaging | Prostate - pathology | Prostate - diagnostic imaging | Intention to Treat Analysis | Prostatic Neoplasms - diagnostic imaging | Quality of Life | Surveys and Questionnaires | Aged | Quality Control | Usage | Magnetic resonance imaging | Biopsy | Men | Diagnosis | Health aspects | Prostate cancer | Medical research | Nuclear magnetic resonance--NMR | Prostate-specific antigen | Urology | Ultrasonic imaging | Hospitals | Risk assessment | Ultrasonography | Prostate | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Prostate-Cancer Mortality at 11 Years of Follow-up
by Schröder, Fritz H and Hugosson, Jonas and Roobol, Monique J and Tammela, Teuvo L.J and Ciatto, Stefano and Nelen, Vera and Kwiatkowski, Maciej and Lujan, Marcos and Lilja, Hans and Zappa, Marco and Denis, Louis J and Recker, Franz and Páez, Alvaro and Määttänen, Liisa and Bangma, Chris H and Aus, Gunnar and Carlsson, Sigrid and Villers, Arnauld and Rebillard, Xavier and van der Kwast, Theodorus and Kujala, Paula M and Blijenberg, Bert G and Stenman, Ulf-Hakan and Huber, Andreas and Taari, Kimmo and Hakama, Matti and Moss, Sue M and de Koning, Harry J and Auvinen, Anssi and ERSPC Investigators and Sahlgrenska akademin and Göteborgs universitet and Gothenburg University and Institute of Clinical Sciences, Section for Oncology, Radiation Physics, Radiology and Urology, Department of Urology and Institutionen för kliniska vetenskaper, sektionen för onkologi, radiofysik, radiologi och urologi, Avdelningen för urologi and Sahlgrenska Academy
The New England Journal of Medicine, ISSN 0028-4793, 03/2012, Volume 366, Issue 11, pp. 981 - 990
The European Randomized Study of Screening for Prostate Cancer continues to show a 21% reduction in prostate-cancer mortality in the screening group, after 11... 
SERVICES TASK-FORCE | MEDICINE, GENERAL & INTERNAL | CONTAMINATION | TIME | ERSPC TRIAL | RANDOMIZED CLINICAL-TRIALS | Age Factors | Follow-Up Studies | Early Detection of Cancer | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Prostatic Neoplasms - diagnosis | Cause of Death | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Aged | Prostatic Neoplasms - prevention & control | Usage | Diagnosis | Prostate cancer | Risk factors | Methods | Cancer | Immune system | Testing | Prostate-specific antigen | Mortality | Men | Death | Prostate | Age | Index Medicus | Abridged Index Medicus | Life Sciences | Prostate-Specific Antigen | Urologi och njurmedicin | diagnosis | prevention & control | blood | Prostatic Neoplasms | mortality | Urology and Nephrology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Screening and Prostate-Cancer Mortality in a Randomized European Study
by Schröder, Fritz H and Hugosson, Jonas and Roobol, Monique J and Tammela, Teuvo L.J and Ciatto, Stefano and Nelen, Vera and Kwiatkowski, Maciej and Lujan, Marcos and Lilja, Hans and Zappa, Marco and Denis, Louis J and Recker, Franz and Berenguer, Antonio and Määttänen, Liisa and Bangma, Chris H and Aus, Gunnar and Villers, Arnauld and Rebillard, Xavier and van der Kwast, Theodorus and Blijenberg, Bert G and Moss, Sue M and de Koning, Harry J and Auvinen, Anssi and ERSPC Investigators and Sahlgrenska akademin and Göteborgs universitet and Gothenburg University and Institute of Clinical Sciences, Section for Oncology, Radiation Physics, Radiology and Urology, Department of Urology and Institutionen för kliniska vetenskaper, sektionen för onkologi, radiofysik, radiologi och urologi, Avdelningen för urologi and Sahlgrenska Academy
The New England Journal of Medicine, ISSN 0028-4793, 03/2009, Volume 360, Issue 13, pp. 1320 - 1328
In this trial, investigators tested the effect of prostate-specific–antigen testing on the death rate from prostate cancer in more than 162,000 men between the... 
DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | RECTAL EXAMINATION | ERSPC TRIAL | SEXTANT BIOPSIES | VALIDATION | QUALITY-OF-LIFE | HEALTH | ROTTERDAM | ANTIGEN | PREDICTION | Digital Rectal Examination | Age Factors | Follow-Up Studies | Humans | Middle Aged | Europe - epidemiology | Male | Risk | Prostatic Neoplasms - diagnosis | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Prostate - pathology | Regression Analysis | Biopsy | Ultrasonography | Prostatic Neoplasms - diagnostic imaging | Quality of Life | Prostatectomy | Registries | Aged | Patient Compliance | Mass Screening - utilization | Studies | Prostate cancer | Mortality | Age | Men | Index Medicus | Abridged Index Medicus | Prostate-Specific Antigen | pathology | ultrasonography | epidemiology | Prostatic Neoplasms | Urologi och njurmedicin | Europe | therapy | diagnosis | utilization | blood | Mass Screening | mortality | Cancer and Oncology | Urology and Nephrology | Prostate | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights